EX-23.1 2 ex23_1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

30 Old Bailey

London

EC4M 7AU

United Kingdom

 

Tel: +44 (0)20 7063 4000

 

www.mazars.co.uk

 

Consent of Independent Registered Public Accounting Firm

 

 

The Board of Directors

Biodexa Pharmaceuticals PLC

Caspian Point

Caspian Way

Cardiff

CF10 4DQ

United Kingdom

 

 

The Board of Directors of Biodexa Pharmaceuticals PLC

 

We consent to the inclusion of our audit report dated April 18, 2024, which is incorporated in the Registration Statements on Form F-1 (No. 333-272693), on the consolidated statement of financial position of Biodexa Pharmaceuticals PLC (the “Company”) and its subsidiaries as of December 31, 2023, 2022 and 2021 and the related consolidated statements of comprehensive income, cash flow, changes in equity for each of the three years in the period ended December 31, 2023, and the related notes which appear in the Form 20-F filed on April 18th, 2024. Our report contains an explanatory paragraph about the existence of substantial doubt concerning Company’s ability to continue as a going concern.

 

We also consent to the reference to us under the caption “Experts” in the Registration Statement.

 

 

/s/ Mazars LLP

 

Mazars LLP

 

London, United Kingdom

 

April 29th, 2024

 

 

Mazars LLP

Mazars LLP is the UK firm of Mazars, an integrated international advisory and accountancy organisation. Mazars LLP is a limited liability partnership registered in England and Wales with registered number OC308299 and with its registered office at 30 Old Bailey, London, EC4M 7AU. Registered to carry on audit work in the UK by the Institute of Chartered Accountants in England and Wales. Details about our audit registration can be viewed at www.auditregister.org.uk under reference number C001139861. VAT number: GB 839 8356 73